Xanthine oxidoreductase-mediated injury is amplified by upregulated AMP deaminase in type 2 diabetic rat hearts under the condition of pressure overload

Y Igaki, M Tanno, T Sato, H Kouzu, T Ogawa… - Journal of Molecular and …, 2021 - Elsevier
Background We previously reported that upregulated AMP deaminase (AMPD) contributes
to diastolic ventricular dysfunction via depletion of the adenine nucleotide pool in a rat …

Translational regulation by miR-301b upregulates AMP deaminase in diabetic hearts

Y Tatekoshi, M Tanno, H Kouzu, K Abe, T Miki… - Journal of Molecular and …, 2018 - Elsevier
AMP deaminase (AMPD) plays a crucial role in adenine nucleotide metabolism. Recently
we found that upregulated AMPD activity is associated with ATP depletion and contractile …

Role of AMP deaminase in diabetic cardiomyopathy

T Miura, H Kouzu, M Tanno, Y Tatekoshi… - Molecular and Cellular …, 2024 - Springer
Diabetes mellitus is one of the major causes of ischemic and nonischemic heart failure.
While hypertension and coronary artery disease are frequent comorbidities in patients with …

Adenosine monophosphate deaminase in the endoplasmic reticulum–mitochondria interface promotes mitochondrial Ca2+ overload in type 2 diabetes rat hearts

A Osanami, T Sato, Y Toda, M Shimizu… - Journal of Diabetes …, 2023 - Wiley Online Library
Abstract Aims/Introduction We previously showed that upregulation of myocardial adenosine
monophosphate deaminase (AMPD) is associated with pressure overload‐induced diastolic …

Excessive degradation of adenine nucleotides by up-regulated AMP deaminase underlies afterload-induced diastolic dysfunction in the type 2 diabetic heart

H Kouzu, T Miki, M Tanno, A Kuno, T Yano… - Journal of molecular and …, 2015 - Elsevier
Type 2 diabetes mellitus (T2DM) is often complicated with diastolic heart failure, which
decompensates under increased afterload. Focusing on cardiac metabolomes, we …

Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy

M Rajesh, P Mukhopadhyay, S Bátkai… - Journal of cellular …, 2009 - Wiley Online Library
In this study, we investigated the effect of the xanthine oxidase (XO) inhibitor, allopurinol
(ALP), on cardiac dysfunction, oxidative‐nitrosative stress, apoptosis, poly (ADP‐ribose) …

Enhanced expression and activity of xanthine oxidoreductase in the failing heart

JW de Jong, RG Schoemaker, R de Jonge… - Journal of Molecular and …, 2000 - Elsevier
The molecular basis for heart failure is unknown, but oxidative stress is associated with the
pathogenesis of the disease. We tested the hypothesis that the activity of xanthine …

Xanthine oxidase inhibition preserves left ventricular systolic but not diastolic function in cardiac volume overload

JD Gladden, BR Zelickson… - American Journal …, 2013 - journals.physiology.org
Xanthine oxidase (XO) is increased in human and rat left ventricular (LV) myocytes with
volume overload (VO) of mitral regurgitation and aortocaval fistula (ACF). In the setting of …

NADPH oxidase mediates oxidative stress and ventricular remodeling through SIRT3/FOXO3a pathway in diabetic mice

J Qiu, D Liu, P Li, L Zhou, L Zhou, X Liu, Y Zhang… - Antioxidants, 2022 - mdpi.com
Oxidative stress and mitochondrial dysfunction are important mechanisms of ventricular
remodeling, predisposed to the development of diabetic cardiomyopathy (DCM) in type 2 …

Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance

H Nambu, S Takada, S Maekawa… - Cardiovascular …, 2021 - academic.oup.com
Aims Exercise intolerance in patients with heart failure (HF) is partly attributed to skeletal
muscle abnormalities. We have shown that reactive oxygen species (ROS) play a crucial …